SINSIN PHARMACEUTICAL Co., LTD.

002800 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩4,560.00
-1.83%
Delayed · cached 15 min

Fair value analysis

002800
SINSIN PHARMACEUTICAL Co., LTD.
Pharmaceuticals›Pharmaceuticals
₩4,560.00
Close used for this calculation
₩10,314.98Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
66/100
Profitability19/25
Returns16/25
Balance Sheet10/25
Efficiency21/25
Growth23/25
Strong
Quality radar
66Prof.19/25Ret.16/25Eff.21/25B.Sht10/25Growth23/25

Consensus fair value

₩10,314.98
Below FV
▲ +126.2% against the close used
Model range ₩3,447.36 – ₩39,640.67
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩3,447.36Fair value₩10,314.98Bull₩39,640.67
FairClose
52-week traded range
52W low ₩4,015.0052W high ₩6,630.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

SINSIN PHARMACEUTICAL Co., LTD. closed at ₩4,560.00, 55.8% below the consensus fair value of ₩10,314.98 drawn from 10 valuation models.

Financial DNA score 66/100 — Strong. P/E of 7.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩9,137.89
+100.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩8,268.18
+81.3%
√(22.5 × EPS × BVPS)
EPS=613, BVPS=4956.52
Graham Formula
₩39,640.67
+769.3%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩12,260.00
+168.9%
EPS × 20x (sector P/E)
EPS=613, Sector P/E=20x
Peter Lynch (PEG)
₩17,715.70
+288.5%
EPS × Growth% (PEG = 1 is fair)
EPS=613, g=28.9%
EV/EBITDA
₩9,952.68
+118.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=10.79B
Dividend Discount (DDM)
₩3,447.36
-24.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=63.84, r=10%, g=8%
Book Value (P/B)
₩7,955.22
+74.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=4956.52, ROE=12.4%, g=6%, r=10%
Reverse DCF
₩4,560.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -6.5% | Historical: 28.9%
Margin of Safety
₩12,995.01
+185.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=17326.68, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.